Abstract:Vascularized lymph node transfer surgery (VLNT) can provide benefit to lymphedema patients. Cytokines may play a role in the development of lymphedema and in the regeneration of lymphatic vessels after VLNT. Our primary aim was to investigate whether the VLNT patients have a specific cytokine profile. Our secondary aim was to see whether the preoperative lymphedema or severity affects the postoperative cytokine response. Wound exudate was gathered from 18 patients undergoing VLNT on the first and sixth postope… Show more
“…Differences in the pro-lymphangiogenic growth factor, VEGF-C were also found among the lymph node dissection group and reconstruction/combined transfer-reconstruction groups [119]. Separate studies have corroborated these findings, noting correlation between IL-10, TNF-α, and TGFβ-1 levels and lymphedema-related factors following lymph node transfer [118]. In the context of lymphaticovenous anastomosis, histological analyses of skin samples showed decreased CD4 + cell inflammation in the lymphedematous limb biopsies, whereas the control limbs showed no difference [120].…”
Section: Surgical Interventionmentioning
confidence: 75%
“…Lymph Node Transfer and Combined Techniques Increased production of IL-10 (after combined lymph node transfer and anastomosis) [118]. Modulation of VEGF-C production, correlation between IL-10, TNF-α, TGFβ-1 and lymphedema-related factors following lymph node transfer [119].…”
Section: Surgical Interventionsmentioning
confidence: 99%
“…It is hypothesized that the engrafted vascularized node transplant encourages local lymphatic regeneration. An analysis of post-operative wound exudates was undertaken to compare inflammatory cytokine profiles in patients with axillary lymph node dissection, breast reconstruction, microvascular lymph node transfer and a combined reconstruction-transplant approach [118]. These studies found that patients with the combined procedure had the highest production of the anti-inflammatory and antifibrotic cytokine, IL-10.…”
Lymphedema is a chronic and progressive disease of the lymphatic system characterized by inflammation, increased adipose deposition, and tissue fibrosis. Despite early hypotheses identifying lymphedema as a disease of mechanical lymphatic disruption alone, the progressive inflammatory nature underlying this condition is now well-established. In this review, we provide an overview of the various inflammatory mechanisms that characterize lymphedema development and progression. These mechanisms contribute to the acute and chronic phases of lymphedema, which manifest clinically as inflammation, fibrosis, and adiposity. Furthermore, we highlight the interplay between current therapeutic modalities and the underlying inflammatory microenvironment, as well as opportunities for future therapeutic development.
“…Differences in the pro-lymphangiogenic growth factor, VEGF-C were also found among the lymph node dissection group and reconstruction/combined transfer-reconstruction groups [119]. Separate studies have corroborated these findings, noting correlation between IL-10, TNF-α, and TGFβ-1 levels and lymphedema-related factors following lymph node transfer [118]. In the context of lymphaticovenous anastomosis, histological analyses of skin samples showed decreased CD4 + cell inflammation in the lymphedematous limb biopsies, whereas the control limbs showed no difference [120].…”
Section: Surgical Interventionmentioning
confidence: 75%
“…Lymph Node Transfer and Combined Techniques Increased production of IL-10 (after combined lymph node transfer and anastomosis) [118]. Modulation of VEGF-C production, correlation between IL-10, TNF-α, TGFβ-1 and lymphedema-related factors following lymph node transfer [119].…”
Section: Surgical Interventionsmentioning
confidence: 99%
“…It is hypothesized that the engrafted vascularized node transplant encourages local lymphatic regeneration. An analysis of post-operative wound exudates was undertaken to compare inflammatory cytokine profiles in patients with axillary lymph node dissection, breast reconstruction, microvascular lymph node transfer and a combined reconstruction-transplant approach [118]. These studies found that patients with the combined procedure had the highest production of the anti-inflammatory and antifibrotic cytokine, IL-10.…”
Lymphedema is a chronic and progressive disease of the lymphatic system characterized by inflammation, increased adipose deposition, and tissue fibrosis. Despite early hypotheses identifying lymphedema as a disease of mechanical lymphatic disruption alone, the progressive inflammatory nature underlying this condition is now well-established. In this review, we provide an overview of the various inflammatory mechanisms that characterize lymphedema development and progression. These mechanisms contribute to the acute and chronic phases of lymphedema, which manifest clinically as inflammation, fibrosis, and adiposity. Furthermore, we highlight the interplay between current therapeutic modalities and the underlying inflammatory microenvironment, as well as opportunities for future therapeutic development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.